dc.creatorLopes Barroso, Livia Ariane [UNIFESP]
dc.creatorSternberg, Flavia [UNIFESP]
dc.creatorInacio de Fraia e Souza, Maria Natalia [UNIFESP]
dc.creatorde Barros Nunes, Gisele Jacobino [UNIFESP]
dc.date.accessioned2020-06-26T16:30:23Z
dc.date.accessioned2022-10-07T20:35:46Z
dc.date.available2020-06-26T16:30:23Z
dc.date.available2022-10-07T20:35:46Z
dc.date.created2020-06-26T16:30:23Z
dc.date.issued2017
dc.identifierAnais Brasileiros De Dermatologia. Rio De Janeiro Rj, v. 92, n. 4, p. 537-539, 2017.
dc.identifier0365-0596
dc.identifierhttps://repositorio.unifesp.br/handle/11600/53516
dc.identifierS0365-05962017000400537.pdf
dc.identifierS0365-05962017000400537
dc.identifier10.1590/abd1806-4841.20175435
dc.identifierWOS:000411799300016
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4019859
dc.description.abstractTrichotillomania is considered a behavioral disorder and is characterized by the recurring habit of pulling one's hair, resulting in secondary alopecia. It affects 1% of the adult population, and 2 to 4.4% of psychiatric patients meet the diagnostic criteria. It can occur at any age and is more prevalent in adolescents and females. Its occurrence in childhood is not uncommon and tends to have a more favorable clinical course. The scalp, eyebrows and eyelashes are the most commonly affected sites. Glutamate modulating agents, such as N-acetylcysteine, have been shown to be a promising treatment. N-acetylcysteine acts by reducing oxidative stress and normalizing glutaminergic transmission. In this paper, we report a case of trichotillomania with an excellent response to N-acetylcysteine.
dc.languageeng
dc.publisherSoc Brasileira Dermatologia
dc.relationAnais Brasileiros De Dermatologia
dc.rightsACESSO ABERTO
dc.subjectAcetylcysteine
dc.subjectAlopecia
dc.subjectGlutamates
dc.subjectTrichotillomania
dc.titleTrichotillomania: a good response to treatment with N-acetylcysteine
dc.typeArtigo


Este ítem pertenece a la siguiente institución